We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SUIG:NASDAQSui Group Holdings Limited Analysis

Data as of 2026-08-31 - not real-time

$0.95

Latest Price

9/10Risk

Risk Level: High

Executive Summary

SUI Group Holdings Limited trades at $0.9479, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Across the trailing 30 sessions it lost 16.1%. With RSI at 46.9 the momentum picture is neutral, alongside a bullish MACD signal. Watch $0.7900 as support and $1.22 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 95.2% above the current quote. Revenue is contracting at 61.7%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 83.6%, a beta of 2.87 and a maximum drawdown of 88.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

Updated Aug 6, 2026 0 WAYZATA, Minn.-- BUSINESS WIRE --Aug 6, 2026-- Sui Group Holdings Limited NASDAQ: SUIG “SUI...Despite a challenging quarter marked by digital asset losses, Sui Group Holdings Ltd SUIG is doubling down on...Seeking Alpha23dSUI Group Holdings Limited SUIG Q2 2026 Earnings Call TranscriptGood afternoon, everyone, and thank you...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.45
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.45
  • Analyst targets imply +95.2% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +95.2% versus the current price
  • Negative return on equity of -683.9%
  • Revenue contracting at -61.7%

Key Metrics & Analysis

Financial Health

Revenue Growth-61.70%
P/E Ratio-7.3
ROE-683.94%
ROA-304.87%
P/B Ratio0.7
Op. Cash Flow$-8025211
Free Cash Flow$-161058272
Industry P/E17.0

Technical Analysis

TrendBearish
RSI46.9
Support$0.79
Resistance$1.22
MA 20$0.93
MA 50$1.05
MA 200$1.45
MACDBullish
VolumeIncreasing
Fear & Greed Index93.96

Valuation

Target Price$1.85
Upside/Downside95.17%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.87
Volatility83.63%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.